March is Multiple Sclerosis Awareness Month, and at MScannaBIZ, we recognize the critical role played by individuals living with MS in the cannabis reform movement. For decades, these patients have been fearless advocates for medical cannabis access across the country.
Even when scientific research was evolving and societal stigma remained strong, people living with MS courageously engaged with lawmakers, shared personal narratives, and fought for safe, legal access to medical cannabis for all patients. One of the most prominent figures in this movement was Cheryl Miller, a New Jersey resident diagnosed with MS in 1971.
The Impact of Advocacy
Cheryl discovered that cannabis alleviated her severe muscle spasms and chronic pain, which had severely limited her mobility. Instead of remaining silent, she and her husband, Jim, became relentless advocates for cannabis reform. In 1998, her civil disobedience act—publicly consuming cannabis outside a congressional office—garnered national attention and highlighted the human aspect of the fight for reform.
Cheryl passed away in 2003, but her legacy lives on through every law empowering medical cannabis patients. New Jersey’s legislation is informally named the “Cheryl Miller Medical Marijuana Act,” underscoring her significant contributions to the cause.
Cannabis as a Treatment for MS
The body of evidence supporting cannabis as a treatment for MS symptoms has grown substantially. Patients are reporting significant relief from symptoms such as muscle stiffness, chronic pain, sleep disturbances, and bladder issues—ailments that can drastically impact quality of life and are often challenging to manage with traditional treatments alone. For many, medical cannabis has not only alleviated their symptoms but also restored their sense of autonomy and dignity.
Thanks to the activism of patients like Cheryl, millions of Americans residing in states with medical cannabis programs now legally access this treatment. However, challenges remain, particularly in states with restrictive policies where many patients still lack access. Furthermore, issues related to cost, availability, and legal uncertainties continue to hinder those seeking medical cannabis.
Looking Forward in Mississippi
As we observe MS Awareness Month, it is crucial to renew our commitment to advocacy in Cheryl’s memory and in the spirit of all MS patients who refuse to accept suffering as the only option. The cannabis industry in Mississippi presents a unique opportunity for reform, empowering patients and enhancing their quality of life through better access to medical cannabis.